“
“Alayacare is excited to be part of the CTS ecosystem. As a software provider serving the home healthcare market, we are continuously integrating innovative monitoring and point of care hardware into our ecosystem. We believe our fellow CTS portfolio companies will be a rich source of innovation for our customers, and at the same time we believe our platform can be an interesting path to market into the community care sector for medical device innovators.”
Adrian SchauerCEO and co founder, Alayacare
“
“CTS Health was a key player in the success of our financing round. The extensive expertise of CTS in supporting marketing of medical devices is reflected at all levels of the organization, the direction to the board. We are proud to form this partnership with them to the international expansion of Thorasys.”
Sébastien JutrasOperation Vice-President, Thorasys
“
“The CTS is the ideal environment to support Greybox in its connected health activities to enable it to break through, grow and succeed. The CTS skills and experience combine with its expertise in the healthcare sector enables Greybox to seize business opportunities and accelerate its commercialization phase. This highly strategic project allows the company to respond to the significant increase planned in its backlog and will lead to the creation of new quality jobs in the health sector in Quebec.”
Pierre BérubéCEO founder, Greybox
“
“We met Yvan and Romain shortly after MIMs’ incorporation in 2016. Followed by a training that allowed us to improve our business model and our value proposition. Their assistance allowed us to establish connections with the organizers of the Quebecois and Canadian Trade Missions, making us known nationally and internationally and initiating our exports. The CTS played a key role in our pre-seed fundraising involving Desjardins Capital and Aligo Innovation. These funds allowed us to finalize the development of the beta version of our platform and to jump-start our marketing phase in an efficient manner.”
Sarah JennaCEO, MIMs
“
“The CTS program allowed us to increase our round of funding by contributing directly to our products commercialization’s acceleration, adding concrete objectives and a key support to rise our company’s valorization.”
David LapointeCEO, Optina
“
“The collaboration with the CTS is effective and formative. They know how to ask the right questions in order to mature projects and accelerate them to the upper level. The flexible support structure allows to quickly meet the whole challenges that a start-up company can live. Real team players!”
Éric MoreauCEO, 03D
“
“Our products give, for the first time, a non invasive access for the clinicians to the digestive system’s deep organs to apply radio-frequencies treatments. With the CTS Santé’s help we keep up more effectively our objective which is to improve therapeutic devices to beat biliary tract and pancreas cancers.”
François PoulinGeneral Director, EMcision International
“
“It’s up to the contractor to light the first stage of the rocket. We could not ask for a better partner than fuel from Desjardins Capital combined with CTS’s in-depth sector expertise to light up the second floor. We are very proud to look at the sky in the same direction.”
Nicolas TremblayPresident, NeuroServo
“
“We are very pleased with the support of Desjardins-Innovatech and the CTS in our founding. The assembly allows Emovi to position itself for its next steps in marketing its technology of evaluation of the knee.”
Michelle LaflammePresident, EMOVI
“
“Montreal has all the tools to be a leader in medical innovation. We have one of the largest populations of students in North-America and one of the best medical in the world. As a scientist-entrepreneur and founder of a medical devices startup I am very happy to count with the support from CTS Santé. The dedication and expertise of CTS Santé’s team were essential for us to raise the first investment round and to solidify partnerships in the industry.”
Margaret MagdesianCEO & Founder, Ananda
“
“Desjardins-Innovatech’s investment and the support of the CTS come at the right time to support our ambitious plans to commercialize our devices in European and North American hospitals. We are pleased to be part of the CTS ecosphere.”
Jean-Luc BalzerPresident, Oxynov
“
“This is the right time for Desjardins-Innovatech investment and the CTS support because they reinforce our ambitious international projects commercialization for our medical’s field tools.”
Martin GaronPresident, Biomomentum
“
“I don’t think an entrepreneur’s worst enemy is complacency. We certainly cannot accuse Yvan and Romain of this scourge which delays a project that has no future. Their involvement in the details says a lot about their passion, which sometimes seems to go beyond our own… Congratulations gentlemen!”
Luc LacroixCEO, Rekruti
“
“Thanks to the CTS and Desjardins-Innovatech, we are able to begin our marketing plan in the United States with representatives dedicated to the sale of the Frequencer, an acoustic airway clearance device. We are pleased to be part of the group of companies supported by the CTS.”
Yvon RobertGeneral Manager, Dymedso
“
“The great expertise of the CTS team and their mastery of health issues have made a real difference in improving Rheabrio’s business plan. Our relationship with the team is dynamic and cheerful, and we benefit from the unmatched business network they provide to access resources with specialized expertise. I am delighted to do business with the CTS!”
Louise BernardPresident, Rheabrio
“
“I had a great experience with the CTS. Their advice and support enabled me to establish a marketing strategy quickly to accelerate our entry into the US and Canadian market. The solid business plan created with them enabled us to close a round of founding in a very short time. Investors were all impressed with the seriousness of the marketing plan as well as the presentation incorporating the advice of the CTS. Their extensive network of contacts quickly propelled sales of our technology into the dental field.”
Frédérik MarcilCEO and founder, Kube Innovation
“
“The CTS team was an important part of MedHelper’s initial financing round. Their thoughtful insights, support and expertise in healthcare were paramount bringing this project to the market. We are proud to have the CTS team behind us!”
Terry FitzpatrickCEO, MedHelper
